Prevalence and diagnostic stability of ADHD and ODD in Turkish children : 4-year longitudinal study by Ercan, Eyüp Sabri et al.
Ercan et al. Child and Adolescent Psychiatry and Mental Health 2013, 7:30
http://www.capmh.com/content/7/1/30RESEARCH Open AccessPrevalence and diagnostic stability of ADHD and
ODD in Turkish children: a 4-year longitudinal
study
Eyüp Sabri Ercan1*, Rasiha Kandulu1, Erman Uslu1, Ulku Akyol Ardic1, Kemal Utku Yazici1, Burge Kabukcu Basay1,
Cahide Aydın1 and Luis Augusto Rohde2Abstract
Background: This study was designed to assess the prevalence of Attention-Deficit/Hyperactivity Disorder (ADHD)
and Oppositional Defiant Disorder (ODD) in a representative sample of second grade students from a country in a
region where no previous rates are available (Turkey). The second aim is to evaluate the differences in ADHD and
ODD prevalence rates among four different waves with one-year gap in reassessments.
Method: Sixteen schools were randomly selected and stratified according to socioeconomic classes. The DSM-IV
Disruptive Behavior Disorders Rating Scale (T-DSM-IV-S) was delivered to parents and teachers for screening in
around 1500 children. Screen positive cases and matched controls were extensively assessed using the K-SADS-PL
and a scale to assess impairment criterion. The sample was reassessed in the second, third and fourth waves with
the same methodology.
Results: The prevalence rates of ADHD in the four waves were respectively 13.38%, 12.53%, 12.22% and 12.91%.
The ODD prevalence was found to be 3.77% in the first wave, 0.96% in the second, 5.41% in the third and 5.35% in
the fourth wave. Mean ODD prevalence was found to be 3.87%.
Conclusions: The prevalence rates of ADHD in the four waves were remarkably higher than the worldwide pooled
childhood prevalence. ADHD diagnosis was quite stable in reassessments after one, two and three years. A mean
ODD prevalence consistent with the worldwide-pooled prevalence was found; but diagnostic stability was much
lower compared to ADHD.
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Attention-Deficit/Hyperactivity Disorder (ADHD) and
Oppositional Defiant Disorder are among the most
common psychiatric disorders of childhood either in
community or clinical samples [1-3]. Moreover, they co-
occur much more frequently than expected by chance
[4]. Both disorders are related with substantial impair-
ment and can be precursors of CD, severe delinquent
behavior and substance use disorders [2,5].
As in any medical conditions, the development of health
strategies directed to early diagnosis and treatment of* Correspondence: eyercan@hotmail.com
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reproduction in any medium, provided the orADHD depends on robust epidemiological data [6]. It is
important to note that a huge variability in prevalence
rates are detected among studies [6]. Although previous
literature clearly suggests that heterogeneity in prevalence
rates of the disorder is associated with methodological
differences among studies [7], there are yet concerns that
ADHD prevalence might be exaggerated in some environ-
ments [8]. Faraone et al. [9] stated that, the predominance
of American research into this disorder over the past
40 years has led to the impression that ADHD is largely
an American disorder and is much less prevalent else-
where. This impression was reinforced by the perception
that ADHD may stem from social and cultural factors that
are most common in American society. Moreover, some
regions of the world were underrepresented in the mosttd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Ercan et al. Child and Adolescent Psychiatry and Mental Health 2013, 7:30 Page 2 of 10
http://www.capmh.com/content/7/1/30comprehensive review of the ADHD epidemiology in
youths [7]. The only significant differences in prevalence
rates were found between North America and both
Middle East and Africa. However, as stated by the authors,
these differences might be an artifact of the small number
of studies in those regions (4 from Middle East and 4 from
Africa) introducing instability in analyses. As stated by
Polanczyk and Jensen [6], more studies conducted in areas
with scarcity of data with better methodologies are needed
to really expand the knowledge on the worldwide preva-
lence of the disorder.
Despite its clinical relevance, surprisingly very little
data is available about ODD prevalence. One possible
reason for this is the fact that several studies imple-
mented the evaluation of ODD in combination with CD
under a category named “conduct problems”. This situ-
ation has its roots in a usual tendency to view ODD
under the umbrella of CD. With rare exceptions, the
epidemiology, comorbidity pattern and course of ODD
were investigated in combination with CD [10]. However
recent studies showed that ODD could be separated
both from CD and normal child behavior and must be
studied independently to be well understood [11].
Studies on ODD prevalence produced a wide range of
rates from 2 to 15% [12-14]. Nock et al. [11] and
Maughan et al. [15] suggested that the important vari-
ation in ODD prevalence might be related to the use of
non-representative samples and inconsistent diagnostic
approaches in the studies. Very recently, the characte-
ristics influencing ODD and CD prevalence worldwide
have been investigated in a systematic review and meta-
regression analysis [16]. The authors have assessed all the
investigations conducted between 1987 and 2008 in their
study. At the end of the assessments, 39 investigations
were found to meet the inclusion criteria and among
them, 25 studies with available data were included in the
review. The pooled prevalence of ODD was estimated to
be 3.3%. The authors reported age as the only covariate
that remained significantly associated with heterogeneity
of results for ODD after the successive deletion of non-
significant variables in the multivariate meta-regression
model. Geographical area was not found to be related with
estimated ODD prevalence. However, it is important to
note that only 4 of the 25 studies were from non-western
countries (3 from Asia, 1 Middle East) and the remaining
21 were from Europe and United States.
One of the most important gaps in the epidemiology
of ADHD and ODD is the fact that age related changes
of these disorders were not thoroughly investigated in
longitudinal community studies [17]. It is known that
ADHD persists through adolescence and adulthood and
15-80% of children diagnosed with ADHD continue to
have the disorder in adulthood, depending on the diag-
nostic criteria used [9,18] However, these findings aremostly derived from follow-up studies relying on clinical
samples of children with ADHD. Recently, Ramtekkar
et al. [19] assessed a huge community sample of subjects
from different ages documenting a decline of ADHD
symptoms and consequently prevalence rates during the
life cycle. However, this was a cross-sectional study.
Similar to ADHD, longitudinal prevalence of ODD has
been very rarely investigated in epidemiological sample.
Nock et al. [11] suggested that ODD mean persistence is
around 6 years. However, many adults diagnosed as
ODD during childhood and adolescence continues to
show ODD symptoms, although diagnostic criteria of
ODD are not currently used in adulthood [11].
This study was conceptualized to provide the following
specific data lacking in the literature: Firstly, to find out
the prevalence rates of ADHD and ODD in a non-referred
representative sample from a country in a region where
no previous rates are available (Turkey). Turkey has also a
specific importance with an interesting geographical
position as a bridge between Europe and Asia. Secondly,
to evaluate the differences in ADHD and ODD prevalence
rates between four different waves with one-year gap in
reassessments. So, the data obtained from the study has
the potential of increasing our knowledge on the develop-
mental epidemiology of ADHD and ODD.
Method
This study is a 4-year longitudinal ADHD and ODD
prevalence investigation. The first year assessment started
with a screening phase in April 2008 when the ADHD
and Disruptive Behavior Scales were sent to parents and
teachers. A study sample was derived at the end of the
screening phase and clinical evaluations (screening posi-
tive cases and matched controls) were performed in May
2008, configuring the first wave of the study. The sample
was reassessed in May 2009, May 2010 and May 2011 in
the second, third and fourth waves of the study.
Sample and screening procedures
Sample
This study has been performed in the central district of
İzmir, which is the third biggest city of Turkey. The
central district of İzmir had a total population of 782.309
inhabitants, 67 government primary schools (from prep
class to 8th grade), a total number of students of about
155.266 and the total number of 2nd graders was 12.667.
The study sample size was calculated to detect ADHD
and ODD prevalence with a precision of 1%, an alpha
error of 5%, and assuming both ADHD and ODD preva-
lence around 5%. Thus, the sample size needed for this
study was estimated to be 1500 students. Sixteen schools
were enrolled by a randomized sampling method among
the total of 67 schools in, İzmir stratified according to
the socioeconomic class categorization of the Ministry
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Among these 16 schools, 1500 cases were selected again
with a randomized sampling method. Parents provided
written informed consents for the participation of their
children and the necessary legal approvals and Universities
Ethical Committee approval were obtained.
Screening procedures
The Turgay DSM-IV Disruptive Behavior Disorders
Rating Scale (T-DSM-IV-S) was used as a screening ins-
trument in this study. The items in the scale are identical
to the list of symptoms described in the DSM-IV criteria
for ADHD (inattention: 9 items, hyperactivity-impulsivity:
9 items), ODD (8 items) and CD (15 items). The T-DSM-
IV-S was developed by Turgay [20] and translated and
adapted in Turkish by Ercan et al. [21]. The symptoms are
scored by assigning a severity estimate for each symp-
tom on a 4-point Likert-type scale (namely, 0 = not at
all; 1 = just a little; 2 =much; and 3 = very much). Ratings
of “much” and “very much” for each item were considered
positive, as done in other similar investigations. Scales
derived from DSM-IV diagnostic criteria for ADHD,
such as the AD/HD Rating Scale IV, have shown
adequate criterion-related validity and good reliability
in different cultures both for parent and teacher re-
ports [22,23]. The same is true for scales derived from
DSM-IV diagnostic criteria for ODD, such as SNAP-
IV ODD [24,25].
T-DSM-IV-S was sent to the parents and teachers of
the 1500 randomly selected cases. Cases with com-
pleted forms were admitted to the study. The cases
with incomplete parent or teacher scales were exclu-
ded. Parent and teacher forms of 1455 cases were
taken back and considered valid, making the response
rate 97%.
For the screening of ADHD; students with at least 5
symptoms of inattention and or hyperactivity/impulsivity
on both teacher and parent scales were considered to
have positive screening for ADHD. This method was
called as “and rule” and it is known to be a conservative
approach. This cutoff point was reported to have a high
sensitivity (82%) and the highest negative predictive
power (96%) for the screening of ADHD in a previous
study [26]. All positively screened subjects and their
parents were invited to participate in the second stage of
the study (N = 86).
Similarly, ODD screening relied on the “and rule”
method. Students with at least 3 symptoms of ODD on
both teacher and parent scales were considered to have
positive screening for ODD. The aim was again to
decrease the false negative ratio. In addition, some inves-
tigators suggested that the threshold of 3 symptoms
might be enough for ODD diagnosis [10,27]. Like the
ADHD screening positive cases, all ODD screeningpositive cases were invited to participate in the second
stage of the study (N = 43).
Among the ADHD screening positive cases (n = 86)
and ODD screening positive cases (n = 43), 59 cases
were only screening positive for ADHD, 16 cases were
only positive for ODD and 27 cases were positive for
both ADHD and ODD. The control groups for ADHD
and ODD screening positive cases were constituted by
screening negative children individually matched for sex
and parental education level. For ADHD, all cases both
in the study group and with one exception in the control
group were enrolled into the study, totalizing 171 cases
(86 positive screening, 85 negative screening). One
screen negative case was excluded since his parents did
not want to participate in the study. In the ODD group,
all the study and control group cases agreed to partici-
pate in the study, so totally 86 cases were recruited for
the study (43 screening positive, 43 screening negative).
Since 27 cases were positive for both ADHD and ODD,
the total number of cases that were enrolled into the study
was 203 (screening positive cases: 86 + 43-27 = 102;
screening negative cases: 86 + 43-27-1 = 101 and total
sample: 102 + 101 = 203) Since the sample of cases that
matched for sex and parental education with the screen
positive cases was larger; a random sample was selected
among them to serve as controls.
Diagnostic procedures
Positive and negative screening cases for ADHD and
ODD diagnoses completed clinical assessments that
included the Schedule for Affective Disorders and
Schizophrenia for School Age Children Present and
Lifetime version (K-SADS-PL) [28]. The K-SADS-PL is a
highly reliable semi-structured interview for the assess-
ment of a wide range of psychiatric disorders. Turkish
reliability and validity study of K-SADS-PL was conducted
by Gokler et al. [29]. Cognitive evaluation relied on the
Vocabulary and Block Design subtests of the WISC-R [30]
that was administered by a trained psychologist to esti-
mate the child’s overall IQ. Parents and teachers were
interviewed by a study nurse to assess the presence of
impairment criterion.
In the evaluation of impairment criteria, firstly parents
were interviewed about 4 areas: the child’s relationships
with his/her sibling(s), friends, ability to do his/her home-
work and general adjustment at home. In the interviews
with teachers, again 4 domains were evaluated: Whether
the patient was considered problematic or not, his/her
relations with friends at school, his/her general success in
subjects and lastly the self-esteem level of the children.
The case was considered to be impaired if he/she was
rated as very problematic in at least one area or a little
problematic in two or more areas. Similar approaches were
previously used in other epidemiologic studies [31,32].
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screening status of the cases. “A best estimate proced-
ure” was used to determine final diagnoses [33]. “Best
estimate procedure” is defined here as determining
diagnostic status after reviewing all teacher and parent’s
scales, semi-structured interviews conducted with parents
and children (K-SADS-PL), WISC-R results, and the
evaluation of impairment criterion by an independent
interviewer in separate interviews conducted with teachers
and parents.
In the 2nd, 3rd and 4th waves of the study, subjects
from both the study and control groups of the first year
were called back for reevaluation in the same school set-
tings. All the procedures of the original study except
than WISC-R were performed to the study participants
by the same researchers in these waves.
In the ADHD group, 3 cases from the study group and
2 cases from the control group could not be reached in
the 2nd wave (response rate of the 2nd year of the study
was determined to be 97%). In the 3rd wave, same 3
cases from the study group could not be reached again
but the two cases of the control group who were not
reached in the 2nd wave were reached this time, making
the total number of cases evaluated in the 3rd wave 168
(response rate = 98%). In the 4th wave, 5 cases from the
study group and 4 cases from the control group could
not be reached that decreased the response rate to
94.7%.
In the ODD group, 3 cases from the study group could
not be reevaluated in the 2nd wave because their parents
refused to take part in this wave; making the total
number to be 83. However, all the cases including the 3
excluded cases of the 2nd wave agreed to take part in
the 3rd wave and the entire original sample were
assessed. Three cases from the study group and 2 cases
from the control group could not be reached in the 4th
wave. Thus the response rates in the 2nd, 3rd and 4th
waves of the study were 96.5%, 100% and 94.2%
respectively.
Data analysis
Prevalence rates of ADHD and ODD were calculated
according to a standard formula as suggested by Rohde
et al. [26]: Pe = cd + nns (1-npv)/n, where Pe is the
estimated prevalence, cd are the cases during the diag-
nostic phase, nns is the number of negative screenings
that were not assessed at diagnostic phase, npv is the
negative predictive value of screening instrument and n
is the sample size. The negative predictive value is the
number of times that the screening instrument said that
the subject was a non-ADHD case and the diagnostic
assessment confirms the subject as a non-ADHD case.
The subtraction of 1-negative predictive value gives the
percentage of correct diagnosis in screening negatives.Thus, multiplying per number of screening negatives
that were not assessed in diagnostic phase gives the
number of potential real cases that were not assessed
because they were screening negatives but have ADHD.
Confidence interval for the estimated prevalence of
ADHD and ODD was calculated with Fleiss Quadratic
approximation method [34]. For the statistical ana-
lysis, chi square test for categorical variables and
paired sample t test for numeric variables were used.
P values less than 0.05 were accepted to be statisti-
cally significant.
Results
The cases were included in analyses only if both the par-
ent and teacher scales were returned and if they were
correctly filled out. Thus out of 1500 children, 1455 (be-
tween 8 to 12 years of age) were included in the screen-
ing phase and the response rate was found to be 97%
(43.1% of the subjects were females and 56.9% males).
Prevalence rates
Using a best estimate procedure, 89 subjects were diag-
nosed as having ADHD (82 of these cases were from
positive, and 7 of them were from negative screening
group) in the wave 1. In the second wave of the study,
68 subjects from screen (+) group and 7 subjects from
screen (−) group were diagnosed as ADHD (total = 75
subjects); in the third wave, 65 subjects from screen (+)
group and 7 subjects from screen (−) group were diag-
nosed to be ADHD (total = 72 subjects) and in the
fourth wave, 53 subjects from screen (+) group and 8
subjects from screen (−) group were diagnosed to be
ADHD (total = 61 subjects). Prevalence rates in each
wave were calculated as the number of cases detected in
the diagnostic phase + number of screening negatives
that were not assessed in diagnostic phase × (1 – negative
predictive value)/sample size. The prevalence rates were
calculated in such a complex way, because simply dividing
the number of cases by the sample size would not count
the cases that have the diagnosis when the screening was
negative. In other words, since no screening test has 100%
accuracy, there are always false negatives. The formula
presented adjusts prevalence for the performance of the
screening instrument. So, ADHD prevalence was calcu-
lated to be 13.38% (95% CI = 11.75-15.43) in the first wave,
12.53% (95% CI = 11.02-14.53) in the second wave, 12.22%
(95% CI = 10.77-14.18) in the third wave and 12.91%
(95% CI = 11.48-16.44) in the fourth wave.
For ODD, 31 cases (29 from positive screening group
and 2 from negative screening group) were diagnosed to
be ODD in the first wave. Since DSM-IV does not allow
ODD diagnosis in the presence of conduct disorder; 8
cases with both ODD and CD diagnosis (“inclusive ODD
diagnosis”) were subtracted from the total number; leaving
Table 1 Distribution of ADHD and ODD diagnosis among
cases according to waves
ADHD diagnosed cases ODD diagnosed cases
Screening
Diagnosis (n) Total Diagnosis (n) Total
(+) (−) (n) (+) (−) (n)
1st WAVE
Screening (+) 82 4 86 22 21 43
Screening (−) 7 78 85 1 42 43
Total 89 82 171 23 63 86
2nd WAVE
Screening (+) 68 15 83 14 26 40
Screening (−) 7 76 83 0 43 43
Total 75 91 166 14 69 83
3rd WAVE
Screening (+) 65 18 83 13 30 43
Screening (−) 7 78 85 2 41 43
Total 72 96 168 15 71 86
4th WAVE
Screening (+) 53 28 81 9 31 40
Screening (−) 8 73 81 2 39 41
Total 61 101 162 11 70 81
ODD Opposition defiant disorder, ADHD Attention Deficit Hyperactivity Disorder.
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screening group) with DSM-IV diagnosis of ODD. In the
second wave, 22 of the first 23 ODD (+) cases and 61 of
63 ODD (−) cases could be assessed and among these, 9
ODD (+) cases were still found to be ODD. Five new cases
from ODD (−) group in the first wave were diagnosed to
be ODD in the second wave making the total number
equal 14. None of the screen negative cases were diag-
nosed as ODD in the second wave of the study. In the
third wave, all the subjects of first wave were reached and
among them 13 subjects from the positive screening
group were diagnosed as ODD. In the third wave of the
study, 2 subjects from the negative screening group was
detected to be ODD making a total number of 15 subjects
to be ODD (+) (10 of these 15 subjects had been assessed
as ODD (+) in the first wave and other 5 were new diag-
nosis). In the fourth wave of the study, 9 subjects from
screen (+) group and 2 subjects from screen (−) group
were diagnosed as ODD (total = 11 subjects; 6 of these 11
subjects had been assessed as ODD (+) in the first wave).
ODD prevalence was found to be 3.78% (95% CI =
3.48-6.33) in the first year, 0.96% (95% CI = 0.95-3.64) in
the second year, 5.42% (95% CI = 5.04-8.27) in the third
year and 5.35% (95% CI = 4.79-10.91) in the fourth year
of the study. When the findings from 4 waves were eval-
uated concomitantly; 13.21% of the cases were found to
be diagnosed as ODD in at least one wave of the study;
while 0.21% of the cases were diagnosed to be ODD in
all three waves. The mean ODD prevalence of three
waves was found to be 3.87%.
Diagnostic stability among waves
It was found that 74 subjects among the ADHD (+) cases
of first wave (89 cases) were still found to be ADHD (+) in
the second wave (3 cases were not reached). One subject
who was ADHD (−) in the first wave received the ADHD
diagnosis, making the total number of ADHD diagnosed
cases 75 in the second wave. Thus 86% of the ADHD (+)
cases of first wave were still ADHD (+) in the second
wave. In the third wave, 70 subjects among the ADHD (+)
cases of first wave were still found to be ADHD (+)
(3 cases were not reached). Two subjects who were
ADHD (−) in the first wave received ADHD diagnosis
making the total number of ADHD diagnosed cases 72 in
the third wave. Thus 81.4% of the ADHD (+) cases of first
wave were still ADHD (+) in the third wave. In the fourth
wave, 57 subjects among the ADHD (+) cases of first wave
and 4 cases of ADHD (−) in the first wave were diagnosed
as ADHD.
Kappa values to estimate test-retest reliability for
ADHD diagnosis were found to be: a) 0.84 between the
first and second waves; b) 0.78 between the first and
third waves; c) 0.62 between first and fourth waves; d) 0.85
between the second and third waves; e) 0.70 betweensecond and fourth waves and f) 0.69 between third and
fourth waves (see Table 1).
Around 41%, 43.5% and 27.3% of ODD cases diag-
nosed in the first wave were still diagnosed to be ODD
in the second and third waves respectively. Kappa values
to estimate the diagnostic test-retest reliability of ODD
were found to be a) 0.37 between the first and second
waves; b) 0.40 between the first and third waves and c)
0.22 between the first and fourth waves (see Table 1).
Comorbid diagnosis
As expected, the main comorbid diagnoses for ADHD in
the four waves were ODD: 61.8%, 45.3%, 40.8%, 39.3;
CD: 18.0%, 17.3%, 12.7%, 24.6%; anxiety disorders:
32.6%, 12.0%, 5.6%, 4.9%; mood disorders: 12.4%, 2.7%,
9.9%, 11.5%; tic disorders: 6.7%, 6.7%, 6.9%, 8.2%; enur-
esis 19.1%, 8.0%, 4.2%, 3.3%, and encopresis 9.0%, 1.3%,
0%, 0% respectively. In addition, also as expected, the
main comorbid diagnose for ODD in the four waves was
ADHD: 87.0%, 92.9%, 100%, 72.7%. The comorbid diag-
noses according to waves are given in Table 2 and
Table 3.
ADHD and ODD correlates
Male predominance was seen in both ODD and ADHD
groups in all three waves of the study although statistical
significance was not obtained (male/female ratio in
ADHD = 3.2, 3.4, 3.5, 5.8 respectively in each wave.
Table 2 Distribution of comorbid diagnoses among ADHD (4) and ADHD (-) cases according to waves
1st wave 2nd wave 3rd wave 4th wave
ADHD (+) ADHD (−) ADHD (+) ADHD (−) ADHD (+) ADHD (−) ADHD (+) ADHD (−)
N = 89 N = 82 N = 75 N = 91 N = 72 N = 96 N = 61 N = 101
n-% n-% n-% n-% n-% n-% n-% n-%
ODD 55–61.8%* 6–7.3%* 34–45.9%**** 5–5.4%**** 29–40.3%* 7–7.3%* 24–39.3% 8–7,9%*
CD 16–18.0%* 1–1.2%* 13–17.6%**** 3–3.3%**** 9–12.5%* –* 15–24,6% 1–1%*
Anxiety Disorders 29–32.6% 18–22% 9–12.2% 6–6.5% 4–5.6% 6–6.3% 3–4.9% 9–8.9%
Mood Disorders 11–12.4% 5–6.1% 2–2.7% 1–1.1% 7-9.7%*** 2.2.1%*** 7–11.5% 1–1%*
Tic Disorders 6–6.7% 4–4.9% 2–2.7% -- 1–1.4% -- 5–8.2% --
Enuresis 17–19.1% 11–13.4% 6–8.1% 5–5.4% 3-4.2% 3–3.1% 2–3.3% 1-1%
Encopresis 8–9.0%** 1–1.2%** 1–1.4% 1–1.1% -- 1–1% -- --
*The comorbidity rates presented are based in the independent sub-samples assessed for ADHD. So, ODD comorbid rates does not match the number of ODD
cases assessed in the ODD sub-sample.
ODD Opposition defiant disorder, CD Conduct Disorder, ADHD Attention Deficit Hyperactivity Disorder.
N = Number of patients with or without ADHD diagnosis, n = number of patients with comorbid diagnosis, % = Percentage of patients with comorbid diagnosis.
Bold values mark statistically significant difference.
*p < 0.001, **p = 0.023, ***p = 0.034.
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each wave). Moreover, no significant difference was found
between the ADHD (+) and (−) cases and ODD (+) and
(−) cases in socio-demographic variables (parent education
and neighborhood) in any wave (data available upon re-
quest). Finally, no significant difference was found be-
tween the ADHD (+) and ADHD (−) cases and ODD (+)
and ODD (−) cases in estimated IQs. (Mean estimated IQ
for ADHD (+) cases: 78.60 (SD: 26.70), for ADHD (−)
cases: 86.06 (SD: 24.68); t = −1.864, df = 164, p = 0.064.
Mean estimated IQ for ODD (+) cases: 86.14 (SD: 29.03),
for ODD (−) cases: 89.52 (SD: 28.59); t = −0.477, df = 83,
p = 0.635).
Discussion
This study is a 4-year longitudinal investigation on the
ADHD and ODD prevalence rates conducted in TurkeyTable 3 Distribution of comorbid diagnoses among ODD (+) a
1st wave 2nd wave
ODD (+) ODD (−) ODD (+) O
N = 23 N = 63 N = 14
n-% n-% n-%
ADHD 20–87.0%* 20–31.7%* 13–92.9%** 32
Anxiety Disorders 7–30.4% 26–41.3% 2–14.3% 5
Mood Disorders 2–8.7% 6–9.5% -- 1
Tic Disorders 2–8.7% 4–6.3% 1–7.1% 1
Enuresis 3–13.0% 12–19.0% 2–14.3% 6
Encopresis 3–13.0% 1–1.6% --
*The comorbidity rates presented are based in the independent sub-samples asses
cases assessed in the ADHD sub-sample.
ODD Opposition defiant disorder, ADHD Attention Deficit Hyperactivity Disorder.
N = Number of patients with or without ODD diagnosis, n = Number of patients wit
Bold values mark statistically significant difference.
*p < 0.001, **p = 0.001.which is an interesting geographical area standing on
the intersection of Europe, Asia and Middle East. It is
important to note that these 3 areas have very few inves-
tigations on the prevalence of child mental disorders
including ADHD and ODD. Our findings on ADHD for
the 4 waves (consecutively 13.38%, 12.53%, 12.22% and
12.91%) were remarkably higher than the worldwide
pooled childhood prevalence of ADHD (6.48%) [7]. On
the other hand, the prevalence rates of ODD were found
to be 3.77%, 0.96%, 5.41%, 5.35% respectively in the first,
second, third and fourth waves and the mean ODD
prevalence was found to be 3.87% which was surpris-
ingly very close to the worldwide pooled prevalence of
ODD (3.3%) [16].
The five main findings from this study were: 1) A
substantially higher prevalence of ADHD in school-age
children in Turkey compared to the one reported in and ODD (−) cases according to waves*
3rd wave 4th wave
DD (−) ODD (+) ODD (−) ODD (+) ODD (−)
N = 69 N = 15 N = 71 N = 11 N = 70
n-% n-% n-% n-% n-%
–46.4%** 15–100%* 30–42.3%* 8–72.7% 20–28.6%*
–7.2% -- 2–2.8% -- 4–5.7%
–1.4% 1-6.7% 4–5.6% -- 3–4.3%
–1.4% -- 1–1.4% 1–9.1% --
–8.7% -- 3–4.2% – 2–2.9%
-- -- -- -- --
sed for ODD. So, ADHD comorbid rates does not match the number of ADHD
h comorbid diagnosis, % = Percentage of patients with comorbid diagnosis.
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different countries [7]. This difference becomes more
important when we consider that diagnostic procedures
followed in our study included even an independent
measure of impairment; 2) The consistency of the 4-year
average ODD prevalence with the literature, in spite of
the fluctuations between the waves; 3) Remarkable true
positivity of screening for ADHD (high positive predict-
ive value), as well as clear stability of the diagnosis and
reliable Kappa values throughout the 4 consecutive
assessments with one year intervals; 4) Lower true posi-
tivity of screening for ODD and less stable ODD diagno-
sis with smaller Kappa values throughout the 4-years
interval compared to ADHD; 5) much larger prevalence
of ODD among boys than girls.
In Turkey, ADHD prevalence was not previously
studied in extensive investigations, but two studies with
diagnostic procedures including only parent and teacher
scales reported the prevalence of ADHD in school age
children between 6–12 and 6–15 years as 8.1% and 8.4
respectively [35,36]. It was interesting to find a higher
ADHD prevalence in spite of the use of stricter metho-
dology in our study. Moreover, ODD and ADHD preva-
lence rates were determined with same methodology but
only ADHD prevalence rates were found to be high
throughout the 4 waves. The ODD prevalence was found
to be much less than the previous studies conducted in
Turkey that was based on scale assessments [35,36].
These results may raise the question “whether ADHD is
more prevalent in Turkish children than some other
parts of the world?” Considering the migratory origin of
Turkish people, which was officially registered with
“sella turcica” in anatomy, and the relation between
migration and DRD4 gene (one of the most important
candidate genes in ADHD etiology) this hypothesis
worth to be investigated [37].
One of the most important aspects of ADHD epidemi-
ology is the course of the disorder across the life span.
The ADHD prevalence tends to decrease with age and
60% of the cases diagnosed as ADHD during childhood
continue to be diagnosed with ADHD in adulthood [38].
But most of the data supporting this idea is derived from
follow-up studies of clinical samples. There are scarce
data from longitudinal non-referred samples [17]. In the
study of Cohen et al. [39] which was an 8 year follow-up
study, ADHD prevalence was found to be 12.8%, 9% and
6% in the same cohort in the following age ranges: 10–
13, 14–16 and 17–20 year. In another study conducted
in Spain among children at 8, 11 and 15 years old,
ADHD prevalence was found to be 14.4%, 5.3% and 3%,
respectively [40], and in another study 6.8% in the same
country [41]. A study from Canada, reported ADHD
prevalence as 5.5%, 4% and 2.5% among 6–8, 9–11 and
12–14 years-old subjects, respectively [42]. When theresults of these studies are evaluated, a 0.5 to 1%
decrease in ADHD prevalence rates in average is found
for each 1-year increase in age. In our study, we detected
a decrease of 0.47% in the prevalence rates of ADHD
between the first and fourth waves which is completely
consistent with previous studies. The future follow up of
the subjects of this study will provide more information
about the lifelong prevalence of ADHD.
One interesting finding was the fluctuation of ODD
prevalence rates among the three waves. It has been
known that variations like presence or absence of diag-
nosis are frequent in longitudinal studies [43]. Lavigne
et al. [44] evaluated 510 children aged 2–5 years old
with ODD for a period of 48–72 months at 5 separate
waves and they stated that part of the fluctuations
among the waves involves a move from exceeding a
diagnostic threshold to a subthreshold status and vice
versa. In our study these fluctuations may be explained
similarly.
While the mean ODD prevalence found in this study
is very consistent with the literature; distribution of the
cases according to sex is quite different than previous
literature findings. Female/male ratio of ODD was around
1/10 in all three waves of our study. This is a quite large
difference, although statistical significance was not
obtained. ODD prevalence was reported to be higher in
boys than in girls in most of the previous studies,
especially in preadolescent period. Among the previous
literature, there is only one study with similar findings to
our results in terms of male/female ODD ratio; but never-
more only in a subgroup of the study (Female/Male = 1/4)
[45]. In that study, disruptive behavior disorders preva-
lence rates were compared among the Puerto Ricans living
in Puerto Rico and New York and male–female difference
was found to be quite large only among the cases between
ages 5–9 living in New York; while in other residency
places and age groups, large differences were not found in
spite of the dominancy of males [45]. Although cultural
variations may be suggested as an explanation for this
result from our study, the findings from another study
conducted previously in Turkey reporting a very close
distribution of ODD cases among boys and girls (55.5% in
boys vs. 44.5% in girls) does not support this view [36]. It
is important to note that there is an active debate on the
applicability of DSM-IV ODD criteria to girls [30,46].
Some authors have suggested that aggression might be
expressed among girls in a different way than boys; covert
aggression may be a more frequently used style among
girls instead of overt aggression [47]. In terms of ADHD
diagnosis, the dominance of boys compared to girls was
an expected finding. The male/female ADHD ratio was
3.2 times higher in male than females in the first wave and
3.4 times higher in the second wave and 3.5 times higher
in the third waves.
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investigated socioeconomic variables in the study and no
statistically significant difference was found between
controls and both ADHD and ODD groups. In an
epidemiological survey from Germany, ADHD was re-
ported to be more frequent among subjects with low
socioeconomic status whereas there were no statistically
significant differences with regard to geographical char-
acteristics (e.g. urban vs. rural) [48]. It has been reported
that ODD and CD occurs most frequent in lower
socioeconomic groups [13,46]. But it has also been
stated that prevalence rates of disruptive behavior
disorder in the disadvantaged neighborhoods compared
with advantaged inner-city neighborhoods have not been
sufficiently documented, and the current evidence on
possible differences in the prevalence of ODD and CD
in rural and urban environments is mixed [2,13].
Limitations
Our findings should be understood in the context of
some limitations. First, this is a regional study of ADHD
and ODD prevalence and the results may not generalize
to other areas of Turkey. Second, we only included
public schools. Therefore, cases found in the top socio-
economic group may not be sufficiently represented.
Thirdly, socioeconomic status was not extensively evaluated
in this study. Finally, we did not assess all possible
comorbidities.
Conclusion
Our findings describe the ADHD prevalence rates and
stability for the first time in a region where no previous
study was conducted implementing a careful and exten-
sive diagnostic procedure. Surprisingly, even after using
strict criteria with impairment assessments, we found a
high ADHD prevalence rate for children at 8 to 10 years
of age. In addition, ADHD diagnosis was quite stable in
reassessments one, two and three years after. Our results
argues against the hypothesis that ADHD is a cultural
construct that is uniquely associated with the United
States or any particular culture. More studies from
regions with no previous epidemiological information on
ADHD will improve our knowledge on the real impact
of cultural diversity in the disorder.
In addition, to the best of our knowledge, this study
was the first longitudinal prevalence study which evalu-
ated ODD in particular by assessing it separately from
CD. This study was designed with the aim to investigate
ODD prevalence in a non-referred school sample, with a
well defined and sufficient sample size, by three stage
evaluation and by considering impairment criteria and
employing best estimate procedure for diagnosis. An
ODD prevalence which was very consistent with the
worldwide pooled prevalence was found in the study butdiagnostic stability was found to be much lower com-
pared to ADHD diagnosis. The results obtained from
this longitudinal study should be confirmed with future
studies using state of the art methodologies in different
regions of Turkey.
Clinical significance
The findings of the study described the ADHD preva-
lence rates and stability for the first time in Turkey
which is a region where no previous study was
conducted implementing a careful and extensive diag-
nostic procedure. In addition, to the best of our
knowledge, this study was the first longitudinal preva-
lence study which evaluated ODD in particular by
assessing it separately from CD. An ODD prevalence
which was very consistent with the worldwide pooled
prevalence was found in the study but diagnostic sta-
bility was found to be much lower compared to
ADHD diagnosis.
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